1. Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities

   • Franziska C. Trudzinski
   • Christina Kellerer
   • Kathrin Kahnert

   Original Paper Open access 31 July 2021 Pages: 177 - 186

   

2. Drug overdose and the risk of cardiovascular diseases: a nested case–control study

   • Wen Qi Gan
   • Jane A. Buxton
   • Amanda K. Slaunwhite

   Original Paper 15 October 2021 Pages: 187 - 196

   

3. Use of fixed-dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia

   • Felix Mahfoud
   • Marita Kieble
   • Martin Schulz

   Original Paper Open access 27 February 2022 Pages: 197 - 202

   

4. Coronary artery disease, left ventricular function and cardiac biomarkers determine all-cause mortality in cancer patients—a large monocenter cohort study

   • Daniel Finke
   • Markus B. Heckmann
   • Lorenz H. Lehmann

   Original Paper Open access 21 March 2022 Pages: 203 - 214

   

5. Clinical cardiovascular phenotypes and the pattern of future events in patients with type 2 diabetes

   • Mariam Elmegaard Malik
   • Charlotte Andersson
   • Morten Schou

   Original Paper 08 April 2022 Pages: 215 - 226

   

6. Prognostic model for atrial fibrillation after cardiac surgery: a UK cohort study

   • Sheng-Chia Chung
   • Benjamin O’Brien
   • Rui Providencia

   Original Paper Open access 05 August 2022 Pages: 227 - 235

   

7. Relationship between non-invasively detected liver fibrosis and in-hospital outcomes in patients with acute coronary syndrome undergoing PCI

   • Flavio Giuseppe Biccirè
   • Francesco Barillà
   • Daniele Pastori

   Original Paper Open access 11 August 2022 Pages: 236 - 246

   

8. Genetic and modifiable risk factors combine multiplicatively in common disease

   • Shichao Pang
   • Loic Yengo
   • Heribert Schunkert

   Original Paper Open access 20 August 2022 Pages: 247 - 257

   

9. Clinical characteristics, causes and predictors of outcomes in patients with in-hospital cardiac arrest: results from the SURVIVE-ARREST study

   • Laura Erika Maria Hannen
   • Betül Toprak
   • Peter Moritz Becher

   Original Paper Open access 17 August 2022 Pages: 258 - 269

   

10. Chronic cigarette smoking is associated with increased arterial stiffness in men and women: evidence from a large population-based cohort

    • Omar Hahad
    • Volker H. Schmitt
    • Thomas Münzel

    Original Paper Open access 06 September 2022 Pages: 270 - 284

11. Secondary prevention in diabetic and nondiabetic coronary heart disease patients: Insights from the German subset of the hospital arm of the EUROASPIRE IV and V surveys

    • K. Ungethüm
    • S. Wiedmann
    • P. U. Heuschmann

    Original Paper Open access 27 September 2022 Pages: 285 - 298

    

12. Hypercholesterolemia diagnosis, treatment patterns and target achievement in patients with acute coronary syndromes in Germany

    • Anselm K. Gitt
    • Klaus G. Parhofer
    • Nikolaus Marx

    Original Paper 17 September 2022 Pages: 299 - 311

    

13. Clinical implications and risk factors for QRS prolongation over time in heart failure patients

    • Martin Berger
    • Nina Kumowski
    • Katharina Schütt

    Original Paper Open access 15 November 2022 Pages: 312 - 322

    

14. Reply to: association between stress hyperglycemia on admission and unfavorable neurological outcome in OHCA patients receiving ECPR (https://doi.org/10.1007/s00392-022-02057-4)

    • Xavier Bemtgen
    • Tobias Wengenmayer
    • Dawid L. Staudacher

    Letter to the Editors Open access 13 September 2022 Pages: 323 - 324

15. Letter to the editor: reply

    • Takuya Taira
    • Akihiko Inoue
    • Shinichi Nakayama

    Letter to the Editors 13 September 2022 Pages: 325 - 326

    

16. Commentary to the article “Transcatheter-based aortic valve replacement vs. isolated surgical aortic valve replacement in 2020”

    • Kurt Bestehorn

    Letter to the Editors Open access 23 November 2022 Pages: 327 - 328

17. Answer to the letter of Dr. Bestehorn

    • Luise Gaede
    • Helge Möllmann

    Letter to the Editors 24 November 2022 Pages: 329 - 329

18. Early and late renal function changes with spironolactone in patients at risk of developing heart failure: findings from the HOMAGE trial

    • João Pedro Ferreira
    • John G. F. Cleland
    • Patrick Rossignol

    Letter to the Editors 24 October 2022 Pages: 330 - 332